StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Aspira Women's Health's ebitda for the twelve months ending Jun 30, 2026 was -$6.73M. For fiscal 2025 it was -$7.80M. The highest annual figure on record is -$7.80M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.80M–
FY2024Dec 31, 2024-$16.19M–
FY2023Dec 31, 2023-$18.65M–
FY2022Dec 31, 2022-$30.87M–
FY2021Dec 31, 2021-$32.29M–
FY2020Dec 31, 2020-$17.72M–
FY2019Dec 31, 2019-$14.95M–
FY2018Dec 31, 2018-$10.66M–
FY2017Dec 31, 2017-$9.66M–
FY2016Dec 31, 2016-$14.23M–
FY2015Dec 31, 2015-$18.96M–
FY2014Dec 31, 2014-$19.07M–
FY2013Dec 31, 2013-$8.79M–
FY2012Dec 31, 2012-$9.33M–
FY2011Dec 31, 2011-$17.56M–
FY2010Dec 31, 2010-$14.49M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.80M–
Q1 FY2026Mar 31, 2026-$2.16M–
Q4 FY2025Dec 31, 2025-$1.25M–
Q3 FY2025Sep 30, 2025-$1.53M–
Q2 FY2025Jun 30, 2025-$1.80M–
Q1 FY2025Mar 31, 2025-$3.23M–
Q4 FY2024Dec 31, 2024-$3.42M–
Q3 FY2024Sep 30, 2024-$3.72M–
Q2 FY2024Jun 30, 2024-$4.37M–
Q1 FY2024Mar 31, 2024-$4.68M–
Q4 FY2023Dec 31, 2023-$4.10M–
Q3 FY2023Sep 30, 2023-$4.08M–
Q2 FY2023Jun 30, 2023-$4.27M–
Q1 FY2023Mar 31, 2023-$6.21M–
Q4 FY2022Dec 31, 2022-$5.02M–
Q3 FY2022Sep 30, 2022-$8.51M–
Q2 FY2022Jun 30, 2022-$8.16M–
Q1 FY2022Mar 31, 2022-$9.18M–
Q4 FY2021Dec 31, 2021-$8.88M–
Q3 FY2021Sep 30, 2021-$9.63M–
Q2 FY2021Jun 30, 2021-$7.99M–
Q1 FY2021Mar 31, 2021-$5.80M–
Q4 FY2020Dec 31, 2020-$5.99M–
Q3 FY2020Sep 30, 2020-$4.22M–
Q2 FY2020Jun 30, 2020-$3.77M–
Q1 FY2020Mar 31, 2020-$3.74M–
Q4 FY2019Dec 31, 2019-$3.35M–
Q3 FY2019Sep 30, 2019-$3.79M–
Q2 FY2019Jun 30, 2019-$4.21M–
Q1 FY2019Mar 31, 2019-$3.60M–
Q4 FY2018Dec 31, 2018-$2.68M–
Q3 FY2018Sep 30, 2018-$2.49M–
Q2 FY2018Jun 30, 2018-$2.85M–
Q1 FY2018Mar 31, 2018-$2.65M–
Q4 FY2017Dec 31, 2017-$2.75M–
Q3 FY2017Sep 30, 2017-$2.30M–
Q2 FY2017Jun 30, 2017-$2.15M–
Q1 FY2017Mar 31, 2017-$2.45M–
Q4 FY2016Dec 31, 2016-$2.63M–
Q3 FY2016Sep 30, 2016-$3.27M–

More Aspira Women's Health figures

See a number that looks wrong?